Direct-To-Consumer Genetic Testing Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Direct-to-Consumer Genetic Testing Market 

5.1. COVID-19 Landscape: Direct-to-Consumer Genetic Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Direct-to-Consumer Genetic Testing Market, By Test Type

8.1. Direct-to-Consumer Genetic Testing Market, by Test Type, 2024-2033

8.1.1 Nutrigenomics Testing

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Predictive Testing

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Carrier Testing

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Skincare testing

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Ancestry & Relationship testing

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Direct-to-Consumer Genetic Testing Market, By Technology Type

9.1. Direct-to-Consumer Genetic Testing Market, by Technology Type, 2024-2033

9.1.1. Target Analysis

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Single Nucleotide Polymorphism (SNP) chips

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Whole Genome Sequencing (WGS)

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Direct-to-Consumer Genetic Testing Market, By Distribution Channel 

10.1. Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2024-2033

10.1.1. Online Platforms

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Over The Counter

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Direct-to-Consumer Genetic Testing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.1.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.1.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.1.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.1.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.2.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.2.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.2.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.2.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.2.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.2.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.3.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.3.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.3.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.3.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.3.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.3.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.4.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.4.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.4.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.4.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.4.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.5.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.5.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Test Type (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Technology Type (2021-2033)

11.5.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2033)

Chapter 12. Company Profiles

12.1. Ancestry

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Color Health, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Easy DNA

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. FamilyTreeDNA

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Full Genome Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Helix OpCo LLC

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Identigene

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Karmagenes

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Living DNA

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Mapmygenome

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms